Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: July 31, 2002
Last updated: March 3, 2008
Last verified: January 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2005
  Estimated Primary Completion Date: No date given